Compound information
- Natural Products
- ZC2751996
- Molecular Formula
- C25H26ClFN4O4
- Molecular Weight
- 500.162661212 g/mol
- Structure
-
- IUPAC Name
- N-(3-chloro-4-fluoro-phenyl)-6-[2-(5,8-dioxa-10-azadispiro[2.0.44.33]undecan-10-yl)ethoxy]-7-methoxy-quinazolin-4-amine
- InChI
- InChI=1S/C25H26ClFN4O4/c1-32-21-12-20-17(23(29-15-28-20)30-16-2-3-19(27)18(26)10-16)11-22(21)33-7-6-31-13-24(4-5-24)25(14-31)34-8-9-35-25/h2-3,10-12,15H,4-9,13-14H2,1H3,(H,28,29,30)
- InChI Key
- OXWUWXCJDBRCCG-UHFFFAOYSA-N
- SMILES
- COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCN1CC2(CC2)C2(C1)OCCO2
- Source
- ZINC000137136675
Warheads
- Cyclopropane
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 35 | Ring Count | 6 |
Heteroatom Count | 10 | Rotatable Bond Count | 7 |
Hydrogen Bond Acceptor Count | 8 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 77.97 Å2 | LogP | 3.956 |
LogS | -4.808 | LogD | 3.642 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.994 | Pgp substrate | 0.562 |
HIA | 0.967 | F20 % | 0.985 |
F30 % | 0.963 | Caco-2 | -4.887 |
MDCK | -5.058 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.223 | PPB | 98.269 |
VD | 2.032 | Fu | 1.357 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.988 | CYP1A2 substrate | 0.72 |
CYP2A6 substrate | 0.569 | CYP2B6 substrate | 0.799 |
CYP2C19 inhibitor | 0.656 | CYP2C19 substrate | 0.878 |
CYP2C8 substrate | 0.869 | CYP2C9 inhibitor | 0.148 |
CYP2C9 substrate | 0.426 | CYP2D6 inhibitor | 0.546 |
CYP2D6 substrate | 0.763 | CYP2E1 substrate | 0.149 |
CYP3A4 inhibitor | 0.675 | CYP3A4 substrate | 0.925 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.055 | CL | 7.933 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.85 | Hepatotoxicity | 0.919 |
Mutagenicity | 0.027 | Rat Oral Acute Toxicity | 0.464 |
FDAMDD | 0.599 | Skin Sensitization | 0.005 |
Carcinogenicity | 0.749 | Eye Corrosion | 0.001 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.882 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.22 | IGC50 | 3.739 |
LC50FM | -6.475 | LC50DM | 3.617 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.38 | NR-AR-LBD | 0.844 |
NR-AhR | 0.776 | NR-Aromatase | 0.677 |
NR-ER | 0.586 | NR-ER-LBD | 0.694 |
NR-PPAR-gamma | 0.451 | SR-ARE | 0.916 |
SR-ATAD5 | 0.863 | SR-HSE | 0.961 |
SR-MMP | 0.915 | SR-p53 | 0.925 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.